Medical News

RSS

Inovio Pharmaceuticals set to be added to Russell 3000 Index

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the company is set to be added to the broad-market Russell 3000® Index when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 25, according to a preliminary list of additions updated on June 18 on www.russell.com.

21 Jun 2010

PHS offers special discounted program for clients utilizing Milliman Care Guidelines

Proven Healthcare Solutions an industry innovator in fortifying hospital compliance with emergency department admission screening, is pleased to introduce the offering of a special discounted program for clients utilizing Milliman Care Guidelines.

21 Jun 2010

Toshiba's Aquilion ONE dynamic volume CT system improves clinical pathway for patients in ERs

Emergency departments are challenged to streamline patient diagnoses and treatment for a variety of conditions and require a CT system capable of imaging patients quickly, accurately and safely. Toshiba America Medical Systems, Inc.'s Aquilion® ONE 320-detector row CT system is designed for such settings and used to evaluate a range of patients, including cardiac, neuro, stroke and pediatric.

21 Jun 2010

Researchers develop intelligent medical sensors to help patients monitor their symptoms

Researchers at the University of Southampton are developing intelligent medical sensors which can be worn by patients to monitor their symptoms and which will alert GPs if medical intervention is needed.

21 Jun 2010

ZIOPHARM Oncology announces guidance on palifosfamide Phase III trial in metastatic soft tissue sarcoma

ZIOPHARM Oncology, Inc. announced guidance today regarding the Company's planned pivotal Phase III trial for palifosfamide in metastatic soft tissue sarcoma, including details of the proposed study's design, timing and regulatory review.

21 Jun 2010

Investment report on NMT Medical released

MicroStockProfit.com announces an investment report featuring NMT Medical Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

21 Jun 2010

PolyTouch Medical's PatchAssist device receives FDA clearance

PolyTouch Medical Ltd., a leading developer of laparoscopic soft tissue prosthetic placement technologies, today announced that it has received broad FDA 510(k) clearance to commercialize PatchAssist. PatchAssist is an innovative laparoscopic surgical instrument that enables accurate and rapid delivery and placement of soft tissue prosthetics for a variety of procedures, including laparoscopic ventral hernia repair.

21 Jun 2010

Total Medical Solutions introduces Supply Recovery program

Total Medical Solutions (TMS) has introduced TMS Supply Recovery, a service that identifies and eliminates unnecessary supply costs in workers' compensation claims.

21 Jun 2010

Cancer survivor organizes first Chattanooga Oral Cancer Awareness Walk

Recently, oral cancer survivor Jeanna Richelson, organized the first Chattanooga Oral Cancer Awareness Walk, which raised donations for the Oral Cancer Foundation, and much needed awareness of a disease that too few Americans know about. According to the foundation's executive director Brian Hill, "I don't believe there has ever been an oral cancer walk that was this successful in its first year. This was an absolutely amazing effort by Jeanna and those who helped her make this possible."

21 Jun 2010

A-Life Medical selected as Finalist for Red Herring's North America 100 award

A-Life Medical, Inc., the pioneer and leading provider of computer-assisted coding (CAC) products and services to the healthcare industry, announced today it has been selected as a Finalist for Red Herring's North America 100 award, a prestigious list honoring the year's most promising private technology ventures from the world's North American business region.

21 Jun 2010

Dyax signs partnership agreement with Sigma-Tau to develop and commercialize subcutaneous DX-88

Dyax Corp. and Defiante Farmaceutica S.A., a subsidiary of the pharmaceutical company Sigma-Tau SpA, announced today a strategic partnership to develop and commercialize subcutaneous DX-88 (ecallantide) for the treatment of hereditary angioedema and other therapeutic indications throughout Europe, North Africa, Middle East and Russia.

21 Jun 2010

Results of two clinical proof-of-concept studies for CER-627 program to be presented at EAS Congress 2010

Cerenis Therapeutics SA, a privately held biopharmaceutical company developing HDL-related compounds for the treatment of cardiovascular and metabolic diseases, today announced it will present the results of two clinical proof-of-concept studies for its CER-627 program (niacin/aspirin combinations) at the 78th European Atherosclerosis Society Congress on June 20-23 in Hamburg, Germany.

21 Jun 2010

OncoGenex initiates Phase 3 Prostate Cancer SATURN Trial

OncoGenex Pharmaceuticals, Inc. announced today the initiation of a Phase 3 registration trial of custirsen sodium (OGX-011/TV-1011), its lead product candidate being developed for the treatment of castrate-resistant prostate cancer (CRPC). This trial, referred to as the Prostate Cancer SATURN Trial, is the first of three Phase 3 trials to be initiated under a global collaboration and license agreement between OncoGenex and Teva Pharmaceutical Industries to develop and commercialize OGX-011/ TV-1011.

21 Jun 2010

FDA accepts ev3's Pipeline Embolization Device PMA for expedited review

ev3 Inc., a global endovascular device company, today announced that the U.S. Food and Drug Administration (FDA) formally accepted for filing the company's Pre-Market Approval (PMA) application for the Pipeline Embolization Device for treatment of large, giant and wide-necked cerebral aneurysms. The FDA's action means that the PMA application was sufficiently complete and ready for substantive review. The filing date for regulatory purposes is May 18, 2010, the date the FDA received ev3's PMA submission.

21 Jun 2010

Researchers develop new drugs that relieve cancer pain without side effects

Researchers at the University of Leicester and the University of Ferrara in Italy have collaborated to develop new drugs which have the potential to relieve cancer pain without causing many of the side effects of current pain-treatments like morphine.

21 Jun 2010

Preliminary top-line results from Hematide Phase 3 program for anemia in chronic renal failure patients

Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.

21 Jun 2010

Sosei reaches agreement to acquire 100% of Activus

Sosei Group Corporation, announced today that it has reached an agreement to acquire 100% of Activus Pharma Ltd., a privately-held biopharmaceutical company based in Chiba, Japan.

21 Jun 2010

Effects of periodic constrictions on drift, diffusion in systems experiencing driving force

An understanding of particle diffusion in the presence of constrictions is essential in fields as diverse as drug delivery, cellular biology, nanotechnology, materials engineering, and spread of pollutants in the soil. When a driving force is applied, displacement of particles occurs as well as diffusion. A paper in the Journal of Chemical Physics, which is published by the American Institute of Physics (AIP), quantifies the effects of periodic constrictions on drift and diffusion in systems experiencing a driving force.

21 Jun 2010

UCLA research sheds light on how brain tells time

The ability to tell time is fundamental to how humans interact with each other and the world. Timing plays an important role, for example, in our ability to recognize speech patterns and to create music. Patterns are an essential part of timing. The human brain easily learns patterns, allowing us to recognize familiar patterns of shapes, like faces, and timed patterns, like the rhythm of a song. But exactly how the brain keeps time and learns patterns remains a mystery.

21 Jun 2010

Beyond Moose and Mountains initiative focuses on building Canada's business and regulatory environment

At its 2010 annual general meeting in Montreal yesterday, the national biotechnology association, BIOTECanada, confirmed a national team of industry leaders, whose expertise will ensure Canada keeps growing what today is an $84 billion bio-economy.

21 Jun 2010

Medical News

Inovio Pharmaceuticals set to be added to Russell 3000 Index

PHS offers special discounted program for clients utilizing Milliman Care Guidelines

Toshiba's Aquilion ONE dynamic volume CT system improves clinical pathway for patients in ERs

Researchers develop intelligent medical sensors to help patients monitor their symptoms

ZIOPHARM Oncology announces guidance on palifosfamide Phase III trial in metastatic soft tissue sarcoma

Investment report on NMT Medical released

PolyTouch Medical's PatchAssist device receives FDA clearance

Total Medical Solutions introduces Supply Recovery program

Cancer survivor organizes first Chattanooga Oral Cancer Awareness Walk

A-Life Medical selected as Finalist for Red Herring's North America 100 award

Dyax signs partnership agreement with Sigma-Tau to develop and commercialize subcutaneous DX-88

Results of two clinical proof-of-concept studies for CER-627 program to be presented at EAS Congress 2010

OncoGenex initiates Phase 3 Prostate Cancer SATURN Trial

FDA accepts ev3's Pipeline Embolization Device PMA for expedited review

Researchers develop new drugs that relieve cancer pain without side effects

Preliminary top-line results from Hematide Phase 3 program for anemia in chronic renal failure patients

Sosei reaches agreement to acquire 100% of Activus

Effects of periodic constrictions on drift, diffusion in systems experiencing driving force

UCLA research sheds light on how brain tells time

Beyond Moose and Mountains initiative focuses on building Canada's business and regulatory environment

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Latest News